Early DNA methylation changes in children developing beta cell autoimmunity at a young age

Area of Science:

• Immunology
• Epigenetics
• Metabolic Diseases

Background:

• Type 1 diabetes (T1D) is a complex autoimmune disease with potential epigenetic links.
• Previous epigenomic studies primarily focused on diagnosed T1D patients.
• Early detection of T1D pathogenesis is crucial for effective management.

Purpose of the Study:

• To investigate early DNA methylation changes associated with T1D before clinical diagnosis or autoantibody appearance.
• To identify cell type-specific epigenetic alterations in T1D development.
• To explore potential epigenetic biomarkers for T1D prediction.

Main Methods:

• Reduced representation bisulphite sequencing (RRBS) was used to analyze DNA methylation in CD4+ T cells, CD8+ T cells, and CD4-CD8- cells.
• Longitudinal peripheral blood mononuclear cell samples from autoantibody-positive individuals and matched controls were analyzed.
• Correlations between DNA methylation and gene expression were explored using RNA sequencing data.

Main Results:

• Differentially methylated regions were identified in all analyzed cell fractions between T1D-positive and control individuals.
• Early DNA methylation signatures, including differential methylation in the IRF5 promoter in CD4+ T cells, were detected in pre-seroconversion samples.
• RRBS findings were validated using pyrosequencing at specific CpG sites.

Conclusions:

• Preliminary findings reveal cell type-specific epigenetic regulation contributing to early T1D pathogenesis.
• Identified DNA methylation patterns may serve as potential biomarkers for T1D prediction.
• Further validation could lead to novel strategies for T1D disease prediction and management.